Browse

Poster Abstracts

P001

EXCEPTIONAL RESPONSE TO MULTIPLE-RECURRENT AND METASTATIC HER-2 POSITIVE OROPHARYNGEAL SQUAMOUS CELL CARCINOMA WITH A PERSONALIZED TREATMENT APPROACH.

Cancer Biology

Nolan B Seim, MD1, Stephen Y Kang, MD1, Riley G Jones, MD2, Manish S Bhandari, MD2, Theodoros N Teknos, MD1

1Department of Otolaryngology-Head and Neck Surgery, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at The Ohio State University Wexner Medical Center, Columbus Ohio, 2Department of Internal Medicine, Division of Medical Oncology, The Christ Hospital, Cincinnati, Ohio


P002

ROLE OF NANOG IN THE RADIORESISTANCE OF HEAD AND NECK CANCER

Cancer Biology

Sei Young Lee, MD1, Se-Heon Kim, MD2, Yunha Kim, PhD1

1Department of Otolaryngology, Chung-Ang University College of Medicine, 2Department of Otorhinolaryngology, Yonsei University College of Medicine


P003

WHOLE-EXOME SEQUENCING ANALYSIS OF NASOPHARYNGEAL CARCINOMA

Cancer Biology

Yong Liu, PhD, MD, Xin Zhang, Prof, PhD, MD, Ming Wei, Gangcai Zhu, Meilin Huang, She Li

Xiangya Hospital, Central South University


P004

INVASION OF HEAD AND NECK SQUAMOUS CELL CANCER CELLS REQUIRES TENASCIN-C EXPRESSION

Cancer Biology

Carissa M Thomas, MD, PhD, Stephen Keysar, PhD, Bettina Miller, Magdalena Glogowska, John I Song, MD, Antonio Jimeno, MD, PhD

University of Colorado School of Medicine


P005

ANALYSIS OF THE LOSS OF CASPASE 8 IN HNSCC USING 3D ORGANOTYPIC CULTURES

Cancer Biology

Antje Lindemann, PhD, Burak Uzunparmak, Jeffrey N Myers, Curtis R Pickering

The University of Texas MD Anderson Cancer Center


P006

GENOME METHYLATION IN ORAL CAVITY CARCINOMAS

Cancer Biology

1, Mariana B dos Reis, Dr1, Mateus C Barros Filho, Dr1, Fábio A Marchi, Dr1, Skirant N Ambatipudi, PhD2, Zdenko N Herceg, PhD2, Silvia R Rogatto, PhD1, Luiz P Kowalski, PhD1

1AC Camargo Cancer Center, 2International Agency for Research on Cancer (IARC)


P007

MIR-520B INHIBITS THE MALIGNANCY OF HEAD-NECK CANCER THROUGH THE SUPPRESSION OF CANCER STEMNESS BY TARGETING CD44

Cancer Biology

Ann-Joy Cheng, PhD1, Ya-Ching Lu1, Joseph T Chang, MD2

1Chang Gung University, 2Chang Gung Memorial Hospital-Linko


P008

CANCER STEM CELL NICHE CORRELATES WITH MALIGNANT PROGRESSION

Cancer Biology

Subin t Surendran1, Gangotri Siddappa2, Ravindra D Ravi2, Christina Mimikos1, Wesley L Hicks1, Amritha Suresh3, Moni A Kuriakose1

1Head and Neck Surgery, Roswell Park Cancer Institute, Buffalo, New York, 14263, 2Mazumdar Shaw Centre for Translational Research, Mazumdar Shaw Medical Centre, Narayana Hrudayalaya, Bangalore, 560099, 3Mazumdar Shaw Medical Center- Roswell Park Collaboration Program, Buffalo, New York 14263


P009

FEASIBILITY OF RECOMBINANT SENDAI VIRUS VECTOR MEDIATED SENTINEL LYMPH NODE TARGETED GENE TRANSFER IN AN ORTHOTOPIC NUDE MOUSE MODEL OF HEAD & NECK SQUAMOUS CELL CARCINOMA

Cancer Biology

Yuya Tanaka, MD1, Koji Araki, MD, PhD1, Shingo Tanaka, MD1, Yoshihiro Miyagawa, MD1, Hiroshi Suzuki, MD1, Daisuke Kamide, MD, PhD1, Taku Yamashita, MD, PhD1, Masayuki Tomifuji, MD, PhD1, Yasuji Ueda, PhD2, Makoto Inoue, PhD2, Akihiro Shiotani, MD, PhD1

1National Defense Medical College, 2ID Pharma Co., Ltd.


P010

PROGNOSTIC VALUE OF ABERRANT PROMOTER HYPERMETHYLATION OF TUMOR-RELATED GENES IN EARLY-STAGE HEAD AND NECK CANCER

Cancer Biology

Kiyoshi Misawa1, Takeharu Kanazawa2, Yuki Misawa1, Hiroyuki Mineta1

1Hamamatsu University School of Medicine, 2Jichi Medical University, Tochigi